Influx Achieves FSSAI Form II Approval for Magnesium Glycinate
Influx Healthtech Ltd, has achieved a milestone by receiving the FSSAI Form II approval for the use of Magnesium Glycinate in tablet, capsule, and liquid preparations. This approval, granted by the FSSAI Scientific Committee, reinforces Influx Healthtech’s commitment to innovation and regulatory compliance. Magnesium Glycinate is a highly bioavailable form…





